Antibody Drug Conjugates: A Leap Ahead in Cancer Treatment

Monoclonal antibody (MAb) based targeted therapies have achieved appreciable success in various branches of drug therapeutics, predominantly when used along with cytotoxic drugs. These immunological therapies based on antibody-drug conjugates (ADCs) have been recently encouraged by the US Food and Drug Administration to treat Solid tumours, Melanoma, Breast Cancer and Hodgkin’s lymphoma. Antibody drug conjugates (ADCs) are an important...